Amneal Pharmaceuticals, Inc.: cash_and_equivalents
| Value | {"amount": 74166000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2017-12-31) |
| Status | current |
| Entity | Amneal Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:37:39.801622+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4e98c1c7-2c5d-4ec0-9958-2fdfb55a2c74
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001723128-18-000030 · Open the official SEC filing →Retrieved: 2026-08-19T17:37:39.801622+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001723128/cash-and-equivalents/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4e98c1c7-2c5d-4ec0-9958-2fdfb55a2c74
History
- supersedes {"amount": 0, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001723128-18-000005)